Work

Supplementary Figure S1 from Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: Schematic map of OV-αCD47 used in this study.

DOI: 10.1158/1078-0432.22483344

Authors: Lei Tian, Bo Xu, Kun-Yu Teng, Mihae Song, Zheng Zhu, Yuqing Chen, Jing Wang, Jianying Zhang, Mingye Feng, Balveen Kaur, Lorna Rodriguez, Michael A. Caligiuri, Jianhua Yu

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute, The University of Texas Health Science Center at Houston

Language: English

Topic: Phagocytosis and Immune Regulation

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Funders: California Institute for Regenerative Medicine, Breast Cancer Alliance, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke

Awards: Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin, G2244471940, Elucidate and Modulate Cell Signaling in NK Cells for Glioma Treatment, scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia, Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19, Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells, G9000226092, Human natural killer cells: Advancing biology and clinical applications, Targeting FLT3 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Identifying and engaging a universal adjuvant for breaking macrophage immune tolerance in cancer

OpenAlex ID: W4361890930

Cites: 38

Cited by:

Related to: 10